In the tumor microenvironment, activation of both proteins protects tumor cells while CTLA-4 regulates the immune response early when the T-cells are activated, and PD-1 acts later on to induce T-cell apoptosis and eventually stop the immune response. Here, PDCD1 is linked to neoplasm.